Active Ingredient(s):Tenapanor Hydrochloride FDA Approved: * September 12, 2019 Pharm Company: *ARDELYX INC Category:Hyperphosphatemia
Tenapanor, used in form of tenapanor hydrochloride and sold under the brand name Ibsrela, is a treatment for adults with a disease of the gut called irritable bowel syndrome with constipation commonly referred to as IBS-C.
Tenapanor is a drug developed by Ardelyx, which acts as an inhibitor of the sodium-proton exchanger NHE3. This antiporter protein is found in the kidney and intestines, and normally acts to regulate the levels of sodium absorbed and secreted by the body. ...
* May have multiple approval dates, manufacturers, or labelers.